CYTO logo

Altamira Therapeutics (CYTO) EV/EBITDA

EV/EBITDA

N/A

Tue, 25 Feb 2025 14:30:00 GMT


Summary


Performance

CYTO EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

OtherCYTOvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

CYTO EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday--14.2%-24.2%
1 m1 month--9.5%-16.8%
3 m3 months--61.7%-75.7%
6 m6 months--78.3%-89.3%
ytdytd--4.0%-7.4%
1 y1 year--68.6%-94.5%
5 y5 years--79.2%-100.0%

CYTO EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month
6 m6-month
1 y1-year
3 y3-year
5 y5-year
alltimeall time-0.04-10.30

Altamira Therapeutics EV/EBITDA History

DateValue
2018
-1.16(+14.9%)
2017
-1.01(+102.0%)
DateValue
2016
-0.50(-85.5%)
2015
-3.46(-1.7%)
2014
-3.52

FAQ

  • What is the all time high EV/EBITDA for Altamira Therapeutics?

What is the all time high EV/EBITDA for Altamira Therapeutics?

Altamira Therapeutics all-time high EV/EBITDA is -0.04